Bonner v. ISP Technologies Inc., 00-3458

Citation259 F.3d 924
Decision Date16 May 2001
Docket NumberNo. 00-3458,00-3458
Parties(8th Cir. 2001) KATIE BONNER, PLAINTIFF/APPELLEE, ESAU BONNER, PLAINTIFF, v. ISP TECHNOLOGIES, INC., DEFENDANT/APPELLANT, CRAWFORD & COMPANY, INC., MOVANT. Submitted:
CourtUnited States Courts of Appeals. United States Court of Appeals (8th Circuit)

Appeal from the United States District Court for the Eastern District of Missouri. [Copyrighted Material Omitted]

[Copyrighted Material Omitted] Before Wollman, Chief Judge, Hansen, Circuit Judge, and Barnes,1 District Judge.

Wollman, Chief Judge.

ISP Technologies, Inc. (ISP) appeals the judgment entered by the district court2 on a jury verdict against it for damages sustained by Katie Bonner. We affirm.

I.

Taking the facts in the light most favorable to the verdict, Katie Bonner was twice exposed to FoamFlush, an organic solvent manufactured by ISP, during her employment on an assembly line in a urethane filter production plant. In March of 1995, the solvent partially dissolved a neoprene hose near Bonner's work station and sprayed over her in a dense mist. In July of 1995, FoamFlush vapors were released from a drum near her work station. Foamflush was used in the plant to clean urethane byproducts from manufacturing equipment. The product was marketed as a "drop-in" replacement for methylene chloride, a carcinogenic solvent, that could be used with systems designed for methylene chloride. FoamFlush contains 57% gamma-butyrolactone (BLO) and three other chemical compounds in smaller quantities. In the human body, BLO metabolizes into gamma-hydroxybutric acid (GHB). Bonner's work station was poorly ventilated at the time of the first exposure, and her protective gear was limited to gloves and goggles.

Bonner alleged three distinct permanent injuries: (1) psychological problems resulting from both her initial exposure and her health problems, (2) cognitive impairment and personality disorders caused by damage to her brain, and (3) Parkinsonian symptoms caused by damage to her brain. At trial, Bonner presented expert witness testimony tending to show that her exposure to FoamFlush caused all three injuries. The case was tried twice in the district court, and Bonner prevailed both times. After the first trial, the district court granted ISP's motion for a new trial because one of Bonner's experts had given testimony that went beyond the scope of his deposition. This appeal is from the second jury verdict, which awarded Bonner $2.2 million for her personal injuries.

II.

ISP argues that the court should have excluded expert witness testimony, that Bonner's evidence was insufficient to support the jury verdict, that the court improperly refused to give two of ISP's proposed jury instructions, and that the court should have granted ISP's motion for a new trial because of the excessiveness of the verdict.

ISP contends that the district court erred in admitting testimony of Dr. Terry Martinez, a pharmacologist and toxicologist, and of Dr. Raymond Singer, a neuropsychologist and neurotoxicologist. It further contends that, because Bonner could not show causation without their testimony, it is entitled to judgment as a matter of law.

To prove causation in a toxic tort case, a plaintiff must show both that the alleged toxin is capable of causing injuries like that suffered by the plaintiff in human beings subjected to the same level of exposure as the plaintiff, and that the toxin was the cause of the plaintiff's injury. See Wright v. Willamette Indus., Inc., 91 F.3d 1105, 1106 (8th Cir. 1996). In other words, the plaintiff must put forth sufficient evidence for a jury to conclude that the product was capable of causing her injuries, and that it did. We have held, however, that "[t]he first several victims of a new toxic tort should not be barred from having their day in court simply because the medical literature, which will eventually show the connection between the victims' condition and the toxic substance, has not yet been completed." Turner v. Iowa Fire Equip. Co., 229 F.3d 1202, 1208-09 (8th Cir. 2000). Bonner did not "need to produce 'a mathematically precise table equating levels of exposure with levels of harm' in order to show" that she was exposed to a toxic level of FoamFlush, "but only 'evidence from which a reasonable person could conclude'" that her exposure probably caused her injuries. Bednar v. Bassett Furniture Mfg. Co., 147 F.3d 737, 740 (8th Cir. 1998) (quoting Wright, 91 F.3d at 1107).

"If scientific, technical, or other specialized knowledge will assist the trier of fact to understand the evidence or to determine a fact in issue, a witness qualified as an expert by knowledge, skill, experience, training, or education, may testify thereto in the form of an opinion or otherwise." Fed. R. Evid. 702. We review under an abuse of discretion standard a district court's ruling admitting expert witness testimony under Rule 702. General Electric Co. v. Joiner, 522 U.S. 136, 141-42 (1997). In Daubert v. Merrill Dow Pharmaceuticals, Inc., 309 U.S. 579 (1993), the Supreme Court detailed the Rule 702 standard for admission of scientific evidence. Although Daubert offers four general criteria3 for assessing the reliability of scientific evidence, it also emphasizes that "[t]he inquiry envisioned by Rule 702 is... a flexible one. Its overarching subject is the scientific validity--and thus the evidentiary relevance and reliability--of the principles that underlie a proposed submission. The focus, of course, must be solely on principles and methodology, not on the conclusions that they generate." 509 U.S. at 594-95. The district court performs a gatekeeping function with respect to scientific evidence, ensuring that evidence submitted to the jury meets Rule 702's criteria for relevance and reliability. Id. at 590-91. The rule's concern with "scientific knowledge" is a reliability requirement, while the requirement that the evidence "assist the trier of fact to understand the evidence or determine a fact in issue" is a relevance requirement. Id.

There is no requirement "that a medical expert must always cite published studies on general causation in order to reliably conclude that a particular object caused a particular illness." Heller v. Shaw Indus., 167 F.3d 146, 155 (3d Cir. 1999); see Turner, 229 F.3d at 1207-08 (citing Heller, 167 F.3d at 155). "[E]ven if the judge believes there are better grounds for some alternative conclusion, and that there are some flaws in the scientist's methods, if there are good grounds for the expert's conclusion, it should be admitted.... [T]he district court could not exclude [scientific] testimony simply because the conclusion was 'novel' if the methodology and the application of the methodology were reliable." Heller, 167 F.3d at 152-53 (internal quotation marks and citation omitted). Likewise, there is no requirement that published epidemiological studies supporting an expert's opinion exist in order for the opinion to be admissible. National Bank of Commerce v. Associated Milk Prods. Inc., 191 F.3d 858, 862 (8th Cir. 1999). Both our cases and the decisions of the Supreme Court make clear that it is the expert witnesses' methodology, rather than their conclusions, that is the primary concern of Rule 702. See Kuhmo Tire Co. v. Carmichael, 526 U.S. 137, 152 (1999); Daubert, 509 U.S. at 594-95; Turner, 229 F.3d at 1209.

Although the district court's gatekeeping function includes an analysis of the reliability of scientific evidence, neither Rule 702 nor Daubert requires that an expert opinion resolve an ultimate issue of fact to a scientific absolute in order to be admissible. Compare Turner, 229 F.3d at 1208 (differential diagnosis admissible when it identifies "the most probable cause" of a condition) with Glastetter v. Novartis Pharm. Corp., 252 F.3d 986, 989 (8th Cir. 2001) (per curiam) (no abuse of discretion in exclusion of differential diagnosis that is "scientifically invalid"). The only question relevant to the admissibility of the scientific evidence is whether it is sufficiently reliable and relevant to assist the jury's determination of a disputed issue. Daubert, 509 U.S. at 594-95.

As a general rule, the factual basis of an expert opinion goes to the credibility of the testimony, not the admissibility, and it is up to the opposing party to examine the factual basis for the opinion in cross-examination. Only if the expert's opinion is so fundamentally unsupported that it can offer no assistance to the jury must such testimony be excluded.

Hose v. Chicago Northwestern Transp. Co., 70 F.3d 968, 974 (8th Cir. 1996) (internal citations and quotations omitted). "Although it is common that medical experts often disagree on diagnosis and causation, questions of conflicting evidence must be left for the jury's determination." Hose, 70 F.3d at 976.

In a pre-trial motion, ISP sought to preclude the admission of Dr. Martinez's opinion that Bonner suffered from permanent and progressive Parkinsonian-type tremors because her exposure to FoamFlush damaged the dopaminergic receptors in her brain, as well as Dr. Singer's opinion that Bonner suffers from permanent organic brain dysfunction consistent with exposure to FoamFlush. The district court precluded Dr. Martinez from testifying that Bonner's permanent Parkinsonian symptoms were caused by FoamFlush exposure, but permitted him to testify that Bonner's acute symptoms were caused by FoamFlush. Dr. Singer was permitted to testify that Bonner suffers from organic brain dysfunction and personality disorders consistent with exposure to a toxic level of FoamFlush.

Dr. Martinez

Dr. Martinez testified at trial that the symptoms Bonner suffered immediately after her exposure to FoamFlush (nausea, headache, tiredness, respiratory problems, trembling, and skin irritation) were caused by that exposure. Dr. Martinez based his testimony on (1) the temporal connection between Bonner's exposure and acute symptoms; (2) animal studies of...

To continue reading

Request your trial
429 cases
  • In re Lipitor (Atorvastatin Calcium) Mktg., Sales Practices & Prods. Liab. Litig.
    • United States
    • U.S. District Court — District of South Carolina
    • January 3, 2017
    ...testimony admissible). Indeed, the examples of immediate onset of symptoms cited above are such examples. See Bonner v. ISP Techs., Inc ., 259 F.3d 924, 931 (8th Cir. 2001) ("Under some circumstances, a strong temporal connection is powerful evidence of causation ... if a person were doused......
  • In re Meridia Products Liability Litigation
    • United States
    • U.S. District Court — Northern District of Ohio
    • July 7, 2004
    ...the substance actually caused the alleged injury. Sterling v. Velsicol Chem. Corp., 855 F.2d 1188 (6th Cir.1988); Bonner v. ISP Techs. Inc., 259 F.3d 924, 928 (8th Cir.2001) ("[t]o prove causation in a toxic tort case, a plaintiff must show both that the alleged toxin is capable of causing ......
  • Honeywell Int'l Inc. v. Icm Controls Corp., Civil No. 11–569 (JNE/TNL).
    • United States
    • U.S. District Court — District of Minnesota
    • August 27, 2014
    ...and it is up to the opposing party to examine the factual basis for the opinion in cross-examination.” Bonner v. ISP Techs., 259 F.3d 924, 929–30 (8th Cir.2001) (quoting Hose v. Chicago Northwestern Transp. Co., 70 F.3d 968, 974 (8th Cir.1996)). With these standards in mind, the Court turns......
  • Medalen v. Tiger Drylac U.S.A., Inc.
    • United States
    • U.S. District Court — District of Minnesota
    • March 31, 2003
    ...to the same level of exposure as the plaintiff, and that the toxin was the cause of the plaintiffs injury." Bonner v. ISP Technologies, Inc., 259 F.3d 924, 928 (8th Cir.2001), citing Wright v. Willamette Indus., Inc., 91 F.3d 1105, 1106 (8th Cir.1996); see also, Mattis v. Carlon Electrical ......
  • Request a trial to view additional results
5 books & journal articles
  • Presenting Your Expert at Trial and Arbitration
    • United States
    • James Publishing Practical Law Books Archive Qualifying & Attacking Expert Witnesses - 2020 Contents
    • August 4, 2020
    ...sufficiently grounded in “good science” to assist the jury constituted an abuse of that court’s discretion. Bonner v. ISP Techs., Inc., 259 F.3d 924, 932 (8th Cir. 2001). §364.2 EXPERT’S LACK OF PARTICULARIZED EXPERTISE OR SPECIFIC EXPERIENCE So long as the expert’s testimony is “within the......
  • Presenting Your Expert at Trial and Arbitration
    • United States
    • James Publishing Practical Law Books Qualifying & Attacking Expert Witnesses
    • May 4, 2022
    ...sufficiently grounded in “good science” to assist the jury constituted an abuse of that court’s discretion. Bonner v. ISP Techs., Inc., 259 F.3d 924, 932 (8th Cir. 2001). §364.2 EXPERT’S LACK OF PARTICULARIZED EXPERTISE OR SPECIFIC EXPERIENCE So long as the expert’s testimony is “within the......
  • Presenting Your Expert at Trial and Arbitration
    • United States
    • James Publishing Practical Law Books Archive Qualifying & Attacking Expert Witnesses - 2021 Contents
    • August 4, 2021
    ...sufficiently grounded in “good science” to assist the jury constituted an abuse of that court’s discretion. Bonner v. ISP Techs., Inc., 259 F.3d 924, 932 (8th Cir. 2001). §364.2 EXPERT’S LACK OF PARTICULARIZED EXPERTISE OR SPECIFIC EXPERIENCE So long as the expert’s testimony is “within the......
  • Presenting Your Expert at Trial and Arbitration
    • United States
    • James Publishing Practical Law Books Archive Qualifying & Attacking Expert Witnesses - 2019 Contents
    • August 4, 2019
    ...sufficiently grounded in “good science” to assist the jury constituted an abuse of that court’s discretion. Bonner v. ISP Techs., Inc., 259 F.3d 924, 932 (8th Cir. 2001). §364.2 EXPERT’S LACK OF PARTICULARIZED EXPERTISE OR SPECIFIC EXPERIENCE So long as the expert’s testimony is “within the......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT